Alterity Therapeutics Ltd
PBN
Company Profile
Business description
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Contact
350 Collins Street
Level 14
MelbourneVIC3000
AUST: +61 393494906
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
10
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,169.00 | 11.10 | 0.14% |
| CAC 40 | 8,022.33 | 20.62 | -0.26% |
| DAX 40 | 22,852.66 | 39.02 | -0.17% |
| Dow JONES (US) | 42,583.32 | 597.97 | 1.42% |
| FTSE 100 | 8,638.01 | 8.78 | -0.10% |
| HKSE | 23,387.86 | 517.70 | -2.17% |
| NASDAQ | 18,188.59 | 404.54 | 2.27% |
| Nikkei 225 | 37,769.83 | 161.34 | 0.43% |
| NZX 50 Index | 12,184.51 | 56.30 | 0.46% |
| S&P 500 | 5,767.57 | 100.01 | 1.76% |
| S&P/ASX 200 | 7,944.10 | 7.20 | 0.09% |
| SSE Composite Index | 3,364.05 | 5.98 | -0.18% |